BamOmaB was founded in 2006 in order to provide newly developed, high-quality reagents for immunological research to the scientific community. These reagents primarily include novel monoclonal antibodies and ELISA-kits developed in the Department of Immunology of the University of Tuebingen. Founders of BAMOMAB are Margret Steinle, Prof. Dr. Hans-Georg Rammensee and Dr. Alexander Steinle.
















BAMOMAB is located in Habsburgerstr. 5, 80801 Munich, Germany.
Margret Steinle who holds an MBA acts as Managing Director.
For further information, please send an e-mail to info@bamomab.com.